Xerox Holdings Corp. has partnered with Vortran Medical Technology to increase the speed and scale production of Vortran”™s GO2Vent ventilator and related Airway Pressure Monitor (APM-Plus) for medical facilities treating COVID-19 patients.
The GO2Vent is used in emergency situations, inter-hospital transport and MRIs before a patient is transferred into an intensive care unit. The gas-operated disposable ventilator can be assembled and discarded after use by a single patient.
According to the companies, this new combined effort will increase ventilator production from approximately 40,000 this month to between 150,000 and 200,000 ventilators a month by June, with the goal of production as many as 1 million ventilators in the coming months. Xerox plans to manufacture the ventilators and APM-Plus devices at its facility outside of Rochester, while Vortran will continue to manufacture ventilators at its current facility in Sacramento; both companies will distribute the products.
“Our smartest minds met virtually with Vortran”™s smartest minds and figured out how to mass produce this critical technology,” said John Visentin, vice chairman and CEO at Norwalk-headquartered Xerox. “We want to help make sure doctors, nurses and paramedics on the frontlines have the resources they need to help the rising number of patients with COVID-19.”
“The partnership with Xerox has one clear goal: to help save as many lives as possible,” added Vortran co-founder and CEO Gordon A. Wong. “With Vortran”™s proven technology and Xerox”™s ability to hyper-scale manufacturing, we believe we can supply healthcare providers as many as 1 million ventilators in the coming months. For all of us, this will be the most important thing we ever do.”
